Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 168 clinical trials
Platinum-Based Chemotherapy Plus Ramucirumab in Patients With Advanced NSCLC Who Have Progressed on First Line Anti-PD-1 Immunotherapy

This is a non-randomized, phase-II study of platinum doublet chemotherapy plus ramucirumab in patients with advanced NSCLC who have progressed on first line anti-PD-1 Immunotherapy. Up to 25 evaluable participants will be enrolled over a period of 2 years. Seven patients will be recruited at the first stage .Eligible patients …

cancer chemotherapy
cancer treatment
lung carcinoma
metastasis
secondary malignant neoplasm of liver
  • 1 views
  • 25 Jan, 2021
  • 1 location
Durvalumab Plus Tremelimumab Combination Immunotherapy With or Without Weekly Paclitaxel in Patients With Advanced Biliary Tract Carcinoma (BTC) After Failure of Platinum-based Chemotherapy

in patients with advanced BTC after failure of platinum-based chemotherapy. On the 25th June 2019, the maximum DLT event number was reached (6/10) in the durvalumab plus tremelimumab

  • 2 views
  • 05 Feb, 2021
  • 42 locations
Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy

gefitinib 250mg in Chinese patients with IIIB or IV NSCLC after failure of platinum-based chemotherapy. Secondary objectives of the study are to obtain the preliminary information on efficacy

cancer chemotherapy
platinum-based chemotherapy
metastasis
gefitinib
pleural effusion
  • 1 views
  • 07 Nov, 2020
  • 1 location
A Study of Maintenance Treatment With Fluzoparib in gBRCA/PALB2 Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy

disease has not progressed on first line platinum based chemotherapy.

blood test
cancer
pancreatic adenocarcinoma
measurable disease
palb2
  • 0 views
  • 01 Feb, 2021
  • 23 locations
Durvalumab in Combination With Chemotherapy in Virus-infected Patients With Non-small Cell Lung Cancer

This is a phase II trial of durvalumab in combination of platinum-based chemotherapy. Patients with stage IV Non-Small-Cell-Lung Cancer (NSCLC) with human immunodeficiency virus (HIV) infection

  • 0 views
  • 26 Jan, 2021
  • 2 locations
Study of Vactosertib in Combination With Durvalumab in Advanced NSCLC

who progressed following platinum-based chemotherapy.

durvalumab
pd-l1
platinum-based chemotherapy
measurable disease
  • 2 views
  • 23 Jan, 2021
  • 0 views
  • 27 Jan, 2021
  • 2 locations
Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer

primary peritoneal cancer after cytoreductive surgery and platinum-based chemotherapy as initial treatment for primary disease or as salvage treatment for first relapse.

primary peritoneal carcinoma
peritoneal cancer
cytoreductive surgery
fallopian tube
platinum-based chemotherapy
  • 36 views
  • 07 Nov, 2020
  • 1 location
Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)

non-small cell lung cancer with progression on or after platinum-based chemotherapy. Plinabulin inhibits tumor growth by targeting both new and existing blood vessels going to the tumor as well

squamous non-small cell lung cancer
measurable disease
systemic therapy
brain metastases
metastasis
  • 0 views
  • 01 Mar, 2021
  • 1 location
Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer

The prognosis for patients with advanced epithelial ovarian cancer remains poor despite aggressive surgical resection and platinum-based chemotherapy. More than 60% of patients will

recurrent disease
paclitaxel
docetaxel
ovarian epithelial cancer
residual tumor
  • 46 views
  • 07 Nov, 2020
  • 1 location